Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Am J Gastroenterol ; 107(7): 1001-10, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22710578

ABSTRACT

OBJECTIVES: Clostridium difficile-associated diarrhea (CDAD) is a major cause of morbidity and increasing health-care costs among hospitalized patients. Although exposure to antibiotics remains the most documented risk factor for CDAD, attention has recently been directed toward a plausible link with proton pump inhibitors (PPIs). However, the results of studies on the association between CDAD and PPIs remain controversial. We have conducted a meta-analysis to summarize the association between PPIs and CDAD among hospitalized patients. METHODS: A systematic search of published literature on studies that investigated the association between PPIs and CDAD from 1990 to 2010 was conducted on Medline and PubMed. The identified articles were reviewed for additional references. The most adjusted risk estimates were extracted by two authors and summarized using random effects meta-analysis. We also conducted a subgroup analysis by study design. Publication bias was evaluated using the Begg and Egger tests. A sensitivity analysis using the Duval and Tweedie "trim-and-fill" method has also been performed. RESULTS: Twenty-three studies including close to 300,000 patients met the inclusion criteria. There was a 65% (summary risk estimate 1.69 with a 95% confidence interval (CI) from 1.395 to 1.974; P<0.000) increase in the incidence of CDAD among patients on PPIs. By study design, whether case-control study (17) or cohort study (6), there was still a significant increase in the incidence of CDAD among PPI users. The risk estimates were 2.31 (95% CI from 1.72 to 3.10; P<0.001) and 1.48 (95% CI from 1.25 to 1.75; P<0.001) for cohort and case-control studies, respectively. CONCLUSIONS: There is sufficient evidence to suggest that PPIs increase the incidence of CDAD. Our meta-analysis shows a 65% increase in the incidence of CDAD among PPI users. We recommend that the routine use of PPIs for gastric ulcer prophylaxis should be more prudent. Establishing a guideline for the use of PPI may help in the future with the judicious use of PPIs. Further studies, preferably prospective, are needed to fully explore the association between PPIs and CDAD.


Subject(s)
Clostridioides difficile , Enterocolitis, Pseudomembranous/chemically induced , Proton Pump Inhibitors/adverse effects , Anti-Bacterial Agents/adverse effects , Enterocolitis, Pseudomembranous/epidemiology , Humans , Incidence , Risk Factors
2.
PLoS One ; 6(7): e21112, 2011.
Article in English | MEDLINE | ID: mdl-21818254

ABSTRACT

Combinatorial libraries of artificial zinc-finger transcription factors (ZF-TFs) provide a robust tool for inducing and understanding various functional components of the cancer phenotype. Herein, we utilized combinatorial ZF-TF library technology to better understand how breast cancer cells acquire resistance to fulvestrant, a clinically important anti-endocrine therapeutic agent. From a diverse collection of nearly 400,000 different ZF-TFs, we isolated six ZF-TF library members capable of inducing stable, long-term anti-endocrine drug-resistance in two independent estrogen receptor-positive breast cancer cell lines. Comparative gene expression profile analysis of the six different ZF-TF-transduced breast cancer cell lines revealed five distinct clusters of differentially expressed genes. One cluster was shared among all 6 ZF-TF-transduced cell lines and therefore constituted a common fulvestrant-resistant gene expression signature. Pathway enrichment-analysis of this common fulvestrant resistant signature also revealed significant overlap with gene sets associated with an estrogen receptor-negative-like state and with gene sets associated with drug resistance to different classes of breast cancer anti-endocrine therapeutic agents. Enrichment-analysis of the four remaining unique gene clusters revealed overlap with myb-regulated genes. Finally, we also demonstrated that the common fulvestrant-resistant signature is associated with poor prognosis by interrogating five independent, publicly available human breast cancer gene expression datasets. Our results demonstrate that artificial ZF-TF libraries can be used successfully to induce stable drug-resistance in human cancer cell lines and to identify a gene expression signature that is associated with a clinically relevant drug-resistance phenotype.


Subject(s)
Breast Neoplasms/pathology , Combinatorial Chemistry Techniques/methods , Drug Resistance, Neoplasm , Peptide Library , Transcription Factors/metabolism , Zinc Fingers , Breast Neoplasms/genetics , Cell Line, Tumor , Cluster Analysis , Drug Resistance, Neoplasm/drug effects , Estradiol/analogs & derivatives , Estradiol/pharmacology , Female , Fulvestrant , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Humans , Treatment Outcome
3.
Mol Cell Biol ; 29(16): 4508-18, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19528233

ABSTRACT

Cell migration requires spatial and temporal processes that detect and transfer extracellular stimuli into intracellular signals. The platelet-derived growth factor (PDGF) receptor is a cell surface receptor on fibroblasts that regulates proliferation and chemotaxis in response to PDGF. How the PDGF signal is transmitted accurately through the receptor into cells is an unresolved question. Here, we report a new intracellular signaling pathway by which DOCK4, a Rac1 guanine exchange factor, and Dynamin regulate cell migration by PDGF receptor endocytosis. We showed by a series of biochemical and microscopy techniques that Grb2 serves as an adaptor protein in the formation of a ternary complex between the PDGF receptor, DOCK4, and Dynamin, which is formed at the leading edge of cells. We found that this ternary complex regulates PDGF-dependent cell migration by promoting PDGF receptor endocytosis and Rac1 activation at the cell membrane. This study revealed a new mechanism by which cell migration is regulated by PDGF receptor endocytosis.


Subject(s)
Cell Movement/physiology , Endocytosis/physiology , Receptor, Platelet-Derived Growth Factor beta/metabolism , Signal Transduction/physiology , Amino Acid Sequence , Animals , Dynamins/genetics , Dynamins/metabolism , GRB2 Adaptor Protein/genetics , GRB2 Adaptor Protein/metabolism , GTPase-Activating Proteins/genetics , GTPase-Activating Proteins/metabolism , Mice , Molecular Sequence Data , NIH 3T3 Cells , Protein Binding , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptor, Platelet-Derived Growth Factor beta/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism
4.
Clin Gastroenterol Hepatol ; 7(7): 749-755.e11, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19345285

ABSTRACT

BACKGROUND & AIMS: Eosinophilic esophagitis (EoE) is characterized by medically/surgically-resistant gastroesophageal reflux symptoms and dense squamous eosinophilia. Studies suggest that histologic assessment of esophageal eosinophilia alone cannot reliably separate patients with EoE from those with gastroesophageal reflux disease (GERD). Our goal was to develop an assay to identify EoE patients and perhaps differentiate EoE from other causes of esophageal eosinophilia. METHODS: A monoclonal antibody specific for an eosinophil secondary granule protein (eosinophil peroxidase [EPX]) was developed and shown to specifically identify intact eosinophils and detect eosinophil degranulation in formalin-fixed specimens. A histopathologic scoring algorithm was developed to analyze data from patient evaluations; the utility of this algorithm was assessed by using archived esophageal tissues from patients with known diagnoses of EoE and GERD as well as controls from 2 tertiary care centers. RESULTS: Intraobserver/interobserver blinded evaluations demonstrated a significant difference (P < .001) between scores of samples taken from control subjects, from patients with esophageal eosinophilia who had a diagnosis of EoE, and from patients with GERD (P < .001). This algorithm also was able to identify patients whose clinical course was suggestive of a diagnosis of EoE, but that nonetheless failed to reach the critical threshold number of > or =15 eosinophils in a high-power (40x) microscopy field. CONCLUSIONS: A novel immunohistochemical scoring system was developed to address an unmet medical need to differentiate histologic specimens from patients with EoE relative to those with GERD. The availability of a unique anti-EPX-specific monoclonal antibody, combined with the ease/rapidity of this staining method and scoring system, will provide a valuable strategy for the assessment of esophageal eosinophilia.


Subject(s)
Biopsy , Eosinophilia/diagnosis , Eosinophilia/pathology , Esophagitis/diagnosis , Esophagitis/pathology , Severity of Illness Index , Adolescent , Adult , Aged , Aged, 80 and over , Algorithms , Animals , Child , Child, Preschool , Diagnosis, Differential , Eosinophilia/immunology , Esophagitis/immunology , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/pathology , Humans , Immunohistochemistry/methods , Infant , Mice , Middle Aged , Staining and Labeling
5.
Clin Cornerstone ; 5(4): 18-29; discussion 30-1, 2003.
Article in English | MEDLINE | ID: mdl-15101492

ABSTRACT

Therapeutic modalities for gastroesophageal reflux disease (GERD) continue to evolve despite the introduction of proton pump inhibitors (PPIs), the most successful antireflux class of drugs. On-demand modalities such as antacids and alginates as well as histamine type-2 receptor antagonists continue to be popular with GERD patients who seek temporary relief of symptoms. The PPIs have revolutionized the treatment of patients with severe erosive esophagitis, complications of GERD, and atypical or extraesophageal manifestations of GERD. Antireflux surgery, commonly performed via laparoscopy, remains popular among patients who do not wish to take medications long term. In addition, the recent introduction of various endoscopic techniques offers GERD patients a long-term solution with less morbidity and lower cost than antireflux surgery.


Subject(s)
Gastroesophageal Reflux/drug therapy , Gastroesophageal Reflux/surgery , Antacids/administration & dosage , Esophagoscopy , Histamine H2 Antagonists/administration & dosage , Humans , Metoclopramide/administration & dosage , Proton Pump Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...